Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 236.100M	--
Mar 5, 2025	2024/Q4	-- / 222.814M	--
Nov 6, 2024	2024/Q3	251.814M / 267.568M	--
Aug 6, 2024	2024/Q2	236.468M / 232.483M	--
May 6, 2024	2024/Q1	240.629M / 217.480M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 236.100M--

Mar 5, 20252024/Q4-- / 222.814M--

Nov 6, 20242024/Q3251.814M / 267.568M--

Aug 6, 20242024/Q2236.468M / 232.483M--

May 6, 20242024/Q1240.629M / 217.480M--

Unlock Free Earnings Estimates

Open Account

Alto Ingredients Earnings Reports

Alto Ingredients | 10-Q: Q3 2024 Earnings Report

Nov 8, 2024 16:26 ET

Alto Ingredients | 8-K: Alto Ingredients, Inc. Reports Third Quarter 2024 Results - Enters CO2 Transportation and Sequestration Agreement with Vault 44.01 -

Nov 6, 2024 16:25 ET

Alto Ingredients | 10-Q: Q2 2024 Earnings Report

Aug 8, 2024 16:40 ET

Alto Ingredients | 8-K: Alto Ingredients, Inc. Reports Second Quarter 2024 Results

Aug 6, 2024 16:27 ET

Trending Stocks

Symbol Mini Chart % Chg

Collegium Pharmaceutical

COLL

+1.32%

Halozyme Therapeutics

HALO